Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor‐4α gene
暂无分享,去创建一个
Jun-Ping Zhang | Ze-Guang Han | Ze-Guang Han | Yue-xiang Chen | W. Xie | Xin Zhang | Wei-Fen Xie | Xin Zeng | Yong Lin | Chuan Yin | Yue-Xiang Chen | Hai-Yan Yue | Jun-Liang Hou | Xing Deng | Xin Zeng | Hai-Yan Yue | C. Yin | J-L Hou | Yong Lin | Xin Zhang | Jun-Ping Zhang | Xing Deng | Ze-Guang Han
[1] K. McGlynn,et al. A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United States , 2006, Cancer Epidemiology Biomarkers & Prevention.
[2] T. Fujimori,et al. Differentiation-inducing therapy for solid tumors. , 2006, Current pharmaceutical design.
[3] Michael F. Clarke,et al. Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.
[4] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[5] C. Jordan. Cancer stem cell biology: from leukemia to solid tumors. , 2004, Current opinion in cell biology.
[6] Jianren Gu,et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity , 2007, International journal of cancer.
[7] J. Adamson,et al. Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis , 2003, Nature Genetics.
[8] M. Weiss,et al. Hepatocyte Nuclear Factor 4 Provokes Expression of Epithelial Marker Genes, Acting As a Morphogen in Dedifferentiated Hepatoma Cells , 1998, The Journal of cell biology.
[9] S. Sell,et al. Stem cell origin of cancer and differentiation therapy. , 2004, Critical reviews in oncology/hematology.
[10] R. Ohno,et al. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate , 2003, Leukemia.
[11] F. Sladek,et al. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. , 2008, Molecular endocrinology.
[12] S. Sell. Potential gene therapy strategies for cancer stem cells. , 2006, Current gene therapy.
[13] D. Ovchinnikov,et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors , 2004, Hepatology.
[14] R Berger,et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.
[15] Jerrold M. Ward,et al. Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis , 2001, Molecular and Cellular Biology.
[16] W. Weinberg,et al. P21Waf1 control of epithelial cell cycle and cell fate. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[17] M. Noguchi,et al. Expression of HNFs and C/EBPα is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes , 2003, Cancer science.
[18] Christopher H. Contag,et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer , 2004, Nature.
[19] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[20] Takahiro Kunisada,et al. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. , 2006, Biochemical and biophysical research communications.
[21] Wenyi Wei,et al. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. , 1997, Science.
[22] S. Duncan,et al. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. , 2000, Genes & development.
[23] A. Gartel,et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[25] 内木 隆文. Analysis of gene expression profile induced by hepatocyte nuclear factor 4α in hepatoma cells using an oligonucleotide microarray , 2002 .
[26] M. Osanai,et al. Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. , 2005, Experimental cell research.
[27] H. Moriwaki,et al. Analysis of Gene Expression Profile Induced by Hepatocyte Nuclear Factor 4α in Hepatoma Cells Using an Oligonucleotide Microarray* , 2002, The Journal of Biological Chemistry.
[28] Stuart H. Orkin,et al. A protein interaction network for pluripotency of embryonic stem cells , 2006, Nature.
[29] I. Ng,et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.
[30] S. Fan,et al. Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.
[31] E. Dmitrovsky,et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.
[32] Nicola J. Rinaldi,et al. Control of Pancreas and Liver Gene Expression by HNF Transcription Factors , 2004, Science.
[33] Goberdhan P Dimri. What has senescence got to do with cancer? , 2005, Cancer cell.